Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends


Award-winning journal providing in-depth analysis on today’s most important topics

State of the States

A roundup of regulatory activity around the country
Summer 2023

New Challenges? New Opportunities

A message from the Chief Executive Officer
Winter 2022-23

Diagnostics As a Defining Touchpoint in the Claims Journey

Timing and accuracy of diagnostic test results can determine the course of an injured worker’s treatment plan and the claim
Winter 2022-23

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

FDA Approves First Over-the-Counter Naloxone Nasal Spray

Patients will no longer need a prescription for this opioid overdose antidote.
Apr 2023

Build Your Army: Maintaining Cybersecurity Amid the IT Talent Gap

A sneak peek into our RISKWORLD 2023 session content focused on cybersecurity strategies in an evolving risk landscape.
Apr 2023

WCRI Publishes Study on Formulary Impacts

How formularies impacted prescriptions across Arkansas, California, Indiana, Kentucky and New York.
Apr 2023

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

FDA Diagnostic Testing Updates

The FDA is working to expedite the delivery of diagnostic testing for COVID-19.
Apr 2020

FDA Addresses Manufacturing Disruptions

Will disruptions in manufacturing result in drug shortages?
Mar 2020

NSAID Use and COVID-19

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
Mar 2020
1 2 3 4